Catyalyst Pharma (CPRX) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.40 +0.06%
EPS Growth %: -30.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -30.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
